Fairchem Organics Ltd (FAIRCHEMOR) — shareholding pattern, promoter holding, financials and share price

About Fairchem Organics Ltd (FAIRCHEMOR)

Fairchem Organics Ltd operates in the Specialty Chemicals industry, within the Chemicals sector. It trades on the NSE as FAIRCHEMOR and on the BSE under scrip code 543252. Its ISIN is INE0DNW01011.

Fairchem Organics Limited was established in 2019, wherein Fairchem Speciality Limited (FSL) transferred the businesses of Oleo chemicals and nutraceuticals as per the scheme of demerger. Fairchem Organics is engaged in manufacturing of specialty chemicals like dimer acid, linoleic acid, mixed tocopherol concentrate and sterols concentrate, which find application in various industries like nutraceuticals, paints, printing ink, detergents, adhesives, etc. [1]

Fairchem Organics is an Indian speciality chemicals manufacturer producing oleo‑chemicals and nutraceutical intermediates (Dimer Acid, Linoleic Acid, Isostearic Acid, Mixed Tocopherols), sourcing low‑cost co‑products from vegetable oil refiners and operating a state‑of‑the‑art plant at Sanand, Gujarat with a 29‑year legacy in green chemistry and process integration.

Q3 and 9M FY26 show a sharp earnings deterioration: 9M revenue fell to INR 3,427 Mn with EBITDA margin compressing to 3.97% and PAT margins to 0.73%, driven by weak paint‑segment demand, cheaper Chinese imports and discontinuation of certain US exports; management cites trade policy changes as the main near‑term recovery lever.

Listed peers in Specialty Chemicals: Sunshield Chemicals Ltd, Sudarshan Pharma Industries Ltd, Shri Ahimsa Naturals Ltd, Indo Amines Ltd, Amal Ltd, Valiant Organics Ltd.

Valuation & Returns

10 Jul 2026

At ₹701.4 a share on 10 Jul 2026, Fairchem Organics Ltd (FAIRCHEMOR) was valued at a price-to-earnings ratio of 159.76x against an industry P/E of 45.11x and a price-to-book of 3.36x on a book value of ₹208.83 per share as of Mar 2026. Solomo computes return on equity of 2.1% and return on capital employed of 3.18% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.

P/E
159.76x
Industry P/E
45.11x
P/B
3.36x
EPS (TTM)
₹4.39
Book value / share
₹208.83
ROE
2.1%
ROCE
3.18%
ROA
1.41%
Debt / equity
0.32x
Dividend yield
1.07%
EBITDA margin
4.8%
52-week range
₹427.9 – ₹994

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Fairchem Organics Ltd (FAIRCHEMOR) reported revenue of ₹460 crore, net profit of ₹6 crore and earnings per share of ₹4.4. That compares with revenue of ₹538 crore and net profit of ₹22 crore in Mar 2025. Figures are standalone, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹116.93 crore and net profit ₹3.69 crore (standalone).

Standalone annual results for Fairchem Organics Ltd (FAIRCHEMOR), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)643648621538460
Net profit (₹ cr)684440226
EPS (₹)52.1533.4131.116.874.4
Compound annual growth for Fairchem Organics Ltd (FAIRCHEMOR). Stock price CAGR is price return and excludes dividends.
Measure5Y3Y1Y
Sales growth3.00%-10.82%-14.55%
Profit growth-33.46%-49.69%-74.78%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 63.26% of Fairchem Organics Ltd (FAIRCHEMOR) (unchanged from the previous quarter), foreign institutional investors (FII) hold 6.34% and domestic institutional investors (DII) hold 2.8%. Market capitalisation was ₹883 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Dec 2020.

Largest disclosed public shareholders in Jun 2026: Massachusetts Institute of Technology 3.33%, Banbridge Limited 3.18%, Public Sector Pension Investment Board - IIFL Asset Management Limited 2.18%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202663.26%-6.34%2.8%36.74%
Mar 202663.26%-6.35%3.99%36.74%
Dec 202561.19%-6.34%5.42%38.81%
Sep 202561.19%-6.18%5.77%38.81%
Jun 202561.19%-6.28%5.77%38.81%
Mar 202561.19%-6.31%5.69%38.81%
Dec 202461.19%-6.31%5.16%38.81%
Sep 202458.7%-6.36%5.16%41.3%
Every quarter since Dec 2020 Filing data, not investment advice.